2022
DOI: 10.1007/s12281-022-00448-8
|View full text |Cite
|
Sign up to set email alerts
|

Current Options in the Diagnosis and Treatment of Monkeypox

Abstract: Purpose of ReviewThis review summarizes the current options for human monkeypox virus diagnostic testing, vaccination, and treatment. Recent Findings Information on non-lesion monkeypox virus diagnostic testing is limited to small studies with unclear sensitivities and specificities. Early data on the JYNNEOS vaccine has shown a lower incidence of monkeypox infection among vaccinated individuals. Drug options for human monkeypox, which include tecovirimat, cidofovir, brincidofovir, and vaccinia immune globulin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…14 The 2022 MPXV outbreak prompted the development of several assays to aid in diagnosis, disease control, and monitoring. 15,16 The RUO MPXV Assay was developed as a blood donation screening assay to be used as a research tool and potentially as needed in response to the outbreak. With the rapid spread of mpox and the uncertainty regarding transfusion transmission early in the outbreak, a potential risk of MPXV to the blood supply could not be ruled out.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…14 The 2022 MPXV outbreak prompted the development of several assays to aid in diagnosis, disease control, and monitoring. 15,16 The RUO MPXV Assay was developed as a blood donation screening assay to be used as a research tool and potentially as needed in response to the outbreak. With the rapid spread of mpox and the uncertainty regarding transfusion transmission early in the outbreak, a potential risk of MPXV to the blood supply could not be ruled out.…”
Section: Discussionmentioning
confidence: 99%
“…Due to continuous threats posed by emerging/re‐emerging infectious diseases, strategies to maintain the availability and safety of the blood supply have been evolving, mainly through enhanced donor screening and testing 14 . The 2022 MPXV outbreak prompted the development of several assays to aid in diagnosis, disease control, and monitoring 15,16 . The RUO MPXV Assay was developed as a blood donation screening assay to be used as a research tool and potentially as needed in response to the outbreak.…”
Section: Discussionmentioning
confidence: 99%
“…However, given that mpox virus disease is a rapidly evolving field, we regularly find new original research articles cropping up. We found several original research articles reporting on treatment options and other aspects of mpox virus disease that were not discussed in previous review articles (DeLaurentis et al, 2022;McCarthy, 2022;Torres, 2022;Rabaan et al, 2023;Shamim et al, 2023). This paper gives a brief analysis of literature from the past till the current time about the pharmacological treatment of the disease and the drugs being administered along with the vaccines being used.…”
Section: Introductionmentioning
confidence: 99%